about
The effect of neurokinin1 receptor blockade on territorial aggression and in a model of violent aggressionExcessive aggression as model of violence: a critical evaluation of current preclinical methods.The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice.Effects of endocannabinoid system modulation on cognitive and emotional behaviorNovel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.Mechanisms differentiating normal from abnormal aggression: glucocorticoids and serotonin.Normal and abnormal aggression: human disorders and novel laboratory models.Glucocorticoid hyper- and hypofunction: stress effects on cognition and aggression.The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats.Classical and novel approaches to the preclinical testing of anxiolytics: A critical evaluation.A comparison of activation patterns of cells in selected prefrontal cortical and amygdala areas of rats which are more or less anxious in response to predator exposure or submersion stress.NR2B subunit-specific NMDA antagonist Ro25-6981 inhibits the expression of conditioned fear: a comparison with the NMDA antagonist MK-801 and fluoxetine.The anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteers.Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field.The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.Behavioral responses to social stress in noradrenaline transporter knockout mice: effects on social behavior and depression.Substance P neurotransmission and violent aggression: the role of tachykinin NK(1) receptors in the hypothalamic attack area.'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze.Mineralocorticoid receptor blockade during a rat's first violent encounter inhibits its subsequent propensity for violence.Genomic and non-genomic effects of glucocorticoids on aggressive behavior in male rats.Chronic glucocorticoid deficiency-induced abnormal aggression, autonomic hypoarousal, and social deficit in rats.CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.Fast positive feedback between the adrenocortical stress response and a brain mechanism involved in aggressive behavior.Interactions between anxiety, social support, health status and buspirone efficacy in elderly patients.Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission.Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: compound-specific and area-specific distribution within the brain.Lasting changes in social behavior and amygdala function following traumatic experience induced by a single series of foot-shocks.The activation of raphe serotonergic neurons in normal and hypoarousal-driven aggression: a double labeling study in rats.Neurochemical characterization of hypothalamic neurons involved in attack behavior: glutamatergic dominance and co-expression of thyrotropin-releasing hormone in a subset of glutamatergic neurons.Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia.Control of the hypothalamo-pituitary-adrenal axis in the neonatal period: adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient brattleboro rats.Pharmacological evaluation of the stress-induced social avoidance model of anxiety.The hypothalamus: cross-roads of endocrine and behavioural regulation in grooming and aggression.Gender-specific effect of maternal deprivation on anxiety and corticotropin-releasing hormone mRNA expression in rats.The effects of vasopressin deficiency on aggression and impulsiveness in male and female rats.Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.Discovery research in neuropsychiatry - anxiety, depression and schizophrenia in focus. Editorial.Effects of resocialization on post-weaning social isolation-induced abnormal aggression and social deficits in rats.
P50
Q28570915-0FF0FFC8-BB05-49BA-BA8B-A4D624446E1CQ30537468-DB0B845D-B7F3-4631-81B2-D9A6E000B1E5Q30540124-42BF8806-C03E-4EED-A23F-77B8A66ECECFQ35209678-0E43934C-136E-40CE-BE50-5E7854184E84Q36035895-61765E34-10F1-4FBD-887A-2A5C9DA7D885Q36310149-5D588811-79E8-4E8F-93EA-793364A552CBQ36399020-E7FBD332-EC28-4A1F-A7C5-D3DB6FB5BA18Q36826920-52CFDDDB-4DB4-4E9C-BE4E-8D63A9740C5EQ37022008-F0AD9C60-C260-4591-8DA7-243633EDC82CQ37286808-B85581A0-1E16-43F8-9231-4B038B54F1FAQ37315479-F3F1D541-D18F-4DC5-A960-FCE4FAF635AAQ38043796-92F26EF4-45AB-4317-8025-D10AF2F712FEQ39290183-BA43E6FC-650C-423F-86BC-134844399A6CQ41791754-9D6AEA4A-A182-434F-B8B1-3E157BD4FE5DQ42641602-D2497E56-629D-4F7B-8D6C-ECD7A029E869Q42663356-8CC71201-60B1-447D-A39C-789573481C0BQ42686860-113E76EA-F970-4F79-B05C-003A121C7383Q44071788-4DCD9D56-2655-4048-AEBB-3BF2CF02E5CEQ44126835-695147A3-C654-4F66-9D13-B8F587BC9FB2Q44386848-4610E80C-2F01-40D7-8A11-5091449B5287Q44780180-991D7DA4-515F-4798-B892-7E54F2B8F7D6Q44812222-356B9B5E-3620-4C39-80A9-3EA56926E34AQ44930687-4ECBA021-E41A-41B1-BE21-EBA7B7F112FDQ44977076-C3736B1E-DEB1-4A4D-95AC-77DC10A0147CQ45126217-2C80B59E-A886-490B-A30A-46D1A70FFE0BQ45195567-AFDF6246-0DE2-4DA5-89F6-3DA3ECD96CA6Q46022737-41F9150C-C478-4ED5-8F8C-6B927638A980Q46079782-214BDAED-7D28-4766-8F3D-AAD1FA5389C9Q46462078-4E243865-A13A-4BB0-9F70-E866DCD12B10Q46499057-4F098A57-F33F-4725-A7BC-42179E1BEC62Q46502435-82373210-B2E1-4782-94BB-C684819C8F28Q46691533-C071EA76-BC25-44FF-B582-0524F208B61EQ46752574-2F8C48B4-1F19-461F-B4B1-66708BF21C7BQ46988340-34E5E577-81A4-4166-B7B2-0B29ADB31240Q47329293-7835C90C-2524-4CE3-801E-C5BAEF4101EEQ47364353-758A189A-13AD-46CC-B859-A791FE7276F6Q47751404-3CD60BFB-A88D-48AA-86A1-4407D98DD7EEQ47781181-32C5E837-2777-4F51-B0B6-79B0D899AC66Q47925403-894E09D1-7A36-4931-A61B-661F8EB5438FQ47940519-33ED2E9F-AD8D-4B57-9686-871B1F4F275D
P50
description
(1958) neurobiológus
@hu
Hongaars onderzoeker
@nl
hulumtues
@sq
researcher
@en
հետազոտող
@hy
name
Haller József
@hu
József Haller
@ast
József Haller
@en
József Haller
@es
József Haller
@nl
József Haller
@sl
type
label
Haller József
@hu
József Haller
@ast
József Haller
@en
József Haller
@es
József Haller
@nl
József Haller
@sl
prefLabel
Haller József
@hu
József Haller
@ast
József Haller
@en
József Haller
@es
József Haller
@nl
József Haller
@sl
P106
P1153
7201959596
P19
P21
P2492
P27
P31
P3226
P3973
P496
0000-0002-1953-3726
P569
1958-11-11T00:00:00Z